Physician profile
Chanderdeep Singh
NPI 1447251889
$14,424.24
in general payments reported to CMS, 2019-2025
34 companies · $668 in 2025
The $668 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,585 · 2020: $2,756 · 2021: $531 · 2022: $1,588 · 2023: $3,337 · 2024: $960 · 2025: $668.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,964.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,964.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $4,939.01 | 2019-2025 | Inspiris Resilia Aortic Valve, Mitris Resilia Mitral Valve, Konect Resilia |
| Atricure, INC. | $4,183.08 | 2019-2025 | Atricure Cryoice Cryoablation System (Cryo2), Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Medtronic Vascular, INC. | $1,776.34 | 2019 | |
| Abiomed | $740.43 | 2022-2025 | Impella |
| Abbott Laboratories | $414.83 | 2022-2025 | Sjm Regent, Mitraclip, Navitor |
| Chiesi USA, INC. | $300.51 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $273.58 | 2023-2024 | |
| Baxter Healthcare | $208.32 | 2019-2023 | Tisseel, Preveleak |
| Boston Scientific Corporation | $155.58 | 2019-2022 | |
| Amgen INC. | $127.89 | 2019-2022 | |
| La Jolla Pharmaceutical Company | $124.48 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $115.15 | 2019-2025 | |
| Medistim USA, INC. | $107.29 | 2023 | Miraq |
| Pfizer INC. | $97.88 | 2019-2022 | |
| Prodigy Surgical Distribution, INC. | $94.32 | 2024 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $87.39 | 2019-2023 | Lifevest |
| Regeneron Healthcare Solutions, INC. | $79.99 | 2019 | |
| Ethicon US, LLC | $79.90 | 2021-2023 | Prolene, Vistaseal, Surgicel Nu-Knit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $73.91 | 2019 | |
| Merck Sharp & Dohme LLC | $70.66 | 2021-2023 | Keytruda |
| Janssen Pharmaceuticals, INC | $51.10 | 2019-2020 | |
| Elutia, INC. | $41.85 | 2020 | |
| Depuy Synthes Sales INC. | $37.51 | 2020 | |
| Teleflex LLC | $36.16 | 2022 | |
| Artivion, INC. | $35.30 | 2021 | |
| Novo Nordisk INC | $29.44 | 2025 | Wegovy |
| Becton, Dickinson and Company | $28.31 | 2025 | Channel Drain |
| Getinge USA Sales, LLC | $22.18 | 2025 | Cardiohelp |
| Esperion Therapeutics, INC. | $20.42 | 2022 | |
| Scpharmaceuticals INC. | $17.57 | 2025 | |
| Roche Diagnostics Corporation | $15.75 | 2020 | |
| Terumo Medical Corporation | $13.83 | 2019 | |
| Portola Pharmaceuticals, LLC | $13.36 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $10.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chanderdeep Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.